Related Experiment Video

Updated: Aug 7, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Chronic paroxysmal hemicrania: from the index patient to the disease

Ottar Sjaastad1

  • 1Department of Neurology, Trondheim, Norway. tora.rui@ntnu.no

Current Pain and Headache Reports
|July 13, 2006
PubMed

Insights

Chronic paroxysmal hemicrania (CPH) is distinct from cluster headache, showing different clinical features and responses to treatment. Indomethacin proved effective for CPH, unlike typical cluster headache medications.

Area of Science:

  • Neurology
  • Headache Medicine

Background:

  • Chronic paroxysmal hemicrania (CPH) is a rare headache disorder.
  • Distinguishing CPH from cluster headache is crucial for effective treatment.

Purpose of the Study:

  • To detail the clinical presentation and diagnostic journey of the first documented patient with CPH.
  • To differentiate CPH from cluster headache based on clinical, autonomic, and therapeutic variables.

Main Methods:

  • Longitudinal case study of a patient diagnosed with CPH.
  • Comparison of clinical attack characteristics, ocular variables, and autonomic features with known cluster headache patterns.
  • Evaluation of treatment response to indomethacin versus cluster headache medications (ergotamine/sumatriptan).

Main Results:

  • The patient experienced CPH with unique attack frequency and duration.
  • Ocular variables and pupillary reactions differed significantly from cluster headache.
  • Indomethacin was highly effective for CPH, while cluster headache drugs were ineffective.
  • Autonomic features like sweating patterns were distinct from cluster headache.

Conclusions:

  • The presented case definitively established CPH as a distinct headache entity.
  • CPH exhibits unique clinical and therapeutic profiles differentiating it from cluster headache.
  • Indomethacin is a key therapeutic agent for CPH.

More Related Videos

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies05:49

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...